Evidence map›Paper›PMID 40400121›Full record

ArticleClinical and translational medicine2025

Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness.

Saharnaz Sarlak, Delphine Marotte, Arthur Karaulic, Jessy Sirera, Alessandra Pierantoni, Meng-Chen Tsai, Roxane Sylvestre, Clement Molina, Arthur Gouraud, Aurélien Bancaud and 9 more

Erratum issuedAbstract read
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Saharnaz SarlakUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Delphine MarotteUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Arthur KaraulicUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Jessy SireraUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Alessandra PierantoniUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Meng-Chen TsaiUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Roxane SylvestreI2MC, Université de Toulouse, Toulouse, France.
Clement MolinaUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Arthur GouraudUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Aurélien BancaudCNRS, LAAS, Toulouse, France.
Paraskevi KousteridouCentre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.
Marie VidalInstitut Méditerranéen de Protonthérapie, Centre Antoine Lacassagne, Fédération Claude Lalanne, Nice, France.
Joël HéraultInstitut Méditerranéen de Protonthérapie, Centre Antoine Lacassagne, Fédération Claude Lalanne, Nice, France.
Jérôme DoyenUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Maeva DufiesUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Florent MorfoisseI2MC, Université de Toulouse, Toulouse, France.
Barbara Garmy-SusiniI2MC, Université de Toulouse, Toulouse, France.
Frédéric LucianoUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.
Gilles PagèsUniversity Cote d'Azur (UCA), Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Nice, France.ORCID https://orcid.org/0000-0002-8466-5610

Funding

ARCAGEING2023020006332 ARCPOST-DOC2021070004080Canceropôle PACACNRS, Université Côte d'AzurFédération Claude LalanneFondation ARC de la Recherche contre le Cancer Programme Labellisé 2022Fondation Estée LauderH2020 TheraLymph 874708Ligue Nationale contre le Cancer (Equipe Labellisée 2019)Met'ConnectPink Ribbon
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40400121
PMCPMC12095174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.